1. Breast cancer statistics, 2022;Giaquinto;CA Cancer J Clin,2022
2. Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer;Copur;N Engl J Med,2021
3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014
4. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012
5. Miller-payne grading and 70-gene signature are associated with prognosis of hormone receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer after neoadjuvant chemotherapy;Wang;Front Oncol,2021